tiprankstipranks
Trending News
More News >
Amagasa Co., Ltd. (JP:3070)
:3070
Japanese Market

Amagasa Co., Ltd. (3070) AI Stock Analysis

Compare
2 Followers

Top Page

JP:3070

Amagasa Co., Ltd.

(3070)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 5.2)
Rating:47Neutral
Price Target:
¥103.00
▲(41.10% Upside)
The score is primarily constrained by weak financial performance (declining revenue, ongoing losses, high leverage, and negative free cash flow). Technical indicators are moderately supportive in the near term (price above key averages and positive MACD), but valuation remains challenged due to loss-making results and no dividend yield data.
Positive Factors
Diversified product portfolio
A broad product mix across household, personal care and health reduces dependence on any single category, smoothing revenue volatility and enabling cross-selling. This structural diversification supports resilience and stable demand over the next 2–6 months as consumption patterns fluctuate.
Multi-channel distribution
Established retail and online distribution plus strategic partner channels provide durable routes-to-market. Multi-channel reach mitigates single-channel disruption, supports scale and customer access, and helps sustain revenue as consumer purchasing increasingly shifts between physical and digital outlets.
Focus on quality, innovation and sustainability
A stated emphasis on quality, innovation and sustainability supports brand differentiation and long-term customer loyalty. These structural advantages help command pricing power, ease regulatory/ESG pressures, and improve shelf placement and partner relationships over multiple quarters.
Negative Factors
Declining revenue and deep losses
Sustained revenue decline and persistent negative margins indicate structural demand or execution issues. Continued losses erode reinvestment capacity and margin recovery prospects, making operational turnaround and durable profitability unlikely without material strategy or product-market changes.
High leverage and weakening equity
Elevated leverage and weakening equity reduce financial flexibility and increase solvency risk. Over months, high debt servicing limits investment in growth or restructuring, raises refinancing risk, and can force asset sales or equity raises that dilute owners and disrupt long-term strategy.
Consistently negative free cash flow
Worsening negative free cash flow signals persistent inability to generate cash from operations. This structural cash gap forces reliance on external financing, constrains capex and inventory investment, and heightens liquidity and continuity risk unless operating cash conversion is restored.

Amagasa Co., Ltd. (3070) vs. iShares MSCI Japan ETF (EWJ)

Amagasa Co., Ltd. Business Overview & Revenue Model

Company DescriptionAmagasa Co., Ltd. plans, develops, wholesales, and retails non-leather women's footwear in Japan. The company offers its products primarily under the JELLY BEANS brand. It also imports and exports women's shoes. It sells its products to specialty shoe stores, department stores, and apparel customers. The company also operates online shops. Amagasa Co., Ltd. was founded in 1976 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyAmagasa Co., Ltd. generates revenue through the direct sale of its consumer products across various distribution channels, including retail partnerships and online platforms. The company has established key revenue streams from its core product lines, which include household goods and personal care items. Additionally, Amagasa may engage in strategic partnerships with other manufacturers and retailers to expand its market reach and product offerings. By leveraging brand loyalty and investing in marketing strategies, the company enhances its sales and profitability.

Amagasa Co., Ltd. Financial Statement Overview

Summary
Financial statements indicate significant stress: declining revenue and deeply negative profitability (income statement weakness), high leverage and weakening equity position (balance sheet risk), and consistently negative and worsening free cash flow (cash flow strain).
Income Statement
20
Very Negative
Amagasa Co., Ltd. has experienced a significant decline in revenue over the years, with a pronounced negative revenue growth rate. The gross profit margin is reducing, and the net profit margin is deeply negative, indicating continuous losses. Both EBIT and EBITDA margins are negative, reflecting operational inefficiencies. The company is struggling to maintain profitability and needs to address its revenue challenges to improve its income statement health.
Balance Sheet
30
Negative
The balance sheet shows a concerning debt-to-equity ratio, indicating high leverage and potential risk. The equity ratio is low, suggesting limited financial stability. The company has also experienced declining stockholders' equity over the years. While there is some cash reserve, the overall financial health is weakened by liabilities exceeding assets significantly, necessitating a strategic focus on reducing debt or increasing equity.
Cash Flow
25
Negative
Amagasa Co., Ltd. has consistently negative free cash flow, which is worsening, indicating poor cash generation from operations. The operating cash flow to net income ratio is negative, further highlighting cash constraints. Despite some positive cash from financing activities, the company struggles with operational cash flow, indicating a need for improved cash management and cost control.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.22B831.62M919.75M1.39B1.57B2.39B
Gross Profit574.43M409.49M531.85M834.47M811.96M1.03B
EBITDA-527.86M-513.94M-589.57M-684.92M-832.21M-752.68M
Net Income-587.63M-519.97M-596.31M-697.67M-861.68M-786.53M
Balance Sheet
Total Assets2.09B629.00M596.43M647.24M948.97M1.37B
Cash, Cash Equivalents and Short-Term Investments521.32M265.17M310.06M312.11M476.62M875.11M
Total Debt856.57M181.78M215.63M252.47M294.91M885.26M
Total Liabilities1.18B423.20M482.96M530.70M626.55M1.31B
Stockholders Equity910.10M205.80M113.47M116.54M322.42M66.05M
Cash Flow
Free Cash Flow0.00-636.94M-615.34M-633.96M-910.83M-653.72M
Operating Cash Flow0.00-621.29M-610.82M-606.53M-886.06M-638.51M
Investing Cash Flow0.00-1.16M62.66M-8.69M-31.53M1.14B
Financing Cash Flow0.00574.87M554.33M448.75M513.99M-154.99M

Amagasa Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price73.00
Price Trends
50DMA
85.20
Positive
100DMA
90.54
Positive
200DMA
146.43
Negative
Market Momentum
MACD
6.33
Positive
RSI
52.92
Neutral
STOCH
22.55
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3070, the sentiment is Neutral. The current price of 73 is below the 20-day moving average (MA) of 96.40, below the 50-day MA of 85.20, and below the 200-day MA of 146.43, indicating a neutral trend. The MACD of 6.33 indicates Positive momentum. The RSI at 52.92 is Neutral, neither overbought nor oversold. The STOCH value of 22.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3070.

Amagasa Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
57
Neutral
¥2.44B151.112.54%
52
Neutral
¥1.80B-26.30-6.40%-590.11%
49
Neutral
¥5.48B-22.482.26%12.99%-364.77%
48
Neutral
¥4.66B-1.96-7.88%-11.22%
47
Neutral
¥7.74B-6.4080.23%63.77%
47
Neutral
¥8.32B17.584.13%-10.82%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3070
Amagasa Co., Ltd.
98.00
-12.00
-10.91%
JP:2778
Palemo Holdings Co.,Ltd.
151.00
4.00
2.72%
JP:7494
Konaka Co., Ltd.
250.00
31.78
14.56%
JP:7603
Mac House Co., Ltd.
182.00
-50.00
-21.55%
JP:8013
NAIGAI Co., Ltd.
297.00
74.00
33.18%
JP:8025
Tsukamoto Corporation Co., Ltd.
1,370.00
342.95
33.39%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 03, 2026